COllaborative Network for NEuro-oncology Clinical Trials

Serving the Global Neuro-Oncology Community

by conducting nimble, scientifically-rational, international trials to demonstrate the safety, feasibility, and early anti-tumor activity of incorporating novel agents and therapeutic modalities into the most effective current regimens for children with newly-diagnosed and recurrent/progressive high-risk brain tumors.

The COllaborative Network for NEuro-oncology Clinical Trials (CONNECT) conducts clinical trials in high-risk pediatric brain tumors (such as DIPG, other high-grade gliomas, and embryonal tumors) to investigate combinations of novel drugs with traditional therapies. We seek to improve outcomes in the worst childhood brain tumors by combining innovative discoveries with “tried and true” therapy regimens through:

 

 

Science & Research

CONNECT member institutions lead the way in cutting edge research in the biology of high-risk pediatric brain tumors. By combining the considerable strengths in basic science and translational expertise among CONNECT’s international members, we can quickly translate basic science discoveries into novel therapies and new cures.

Collaboration & Service

CONNECT is a global partnership of world-class childhood cancer centers and pediatric neuro-oncology experts. The international collaboration expands global access to novel, promising therapies for children and young adults with brain tumors, and improves scientific discovery through multidisciplinary collaboration.

Support CONNECT

Interested in becoming a funding partner or donating to CONNECT? Click below to contact us or make a donation.